NCT01843556View on ClinicalTrials.gov

A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

June 30, 2013

Conditions
Healthy Elderly Male
Interventions
DRUG

E2022 Tape Formulation

E2022 tape formulation applied to different application sites and at different intervals in Japanese healthy elderly males

Trial Locations (1)

Unknown

Kagoshima

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT01843556 - A Phase 1 Study of E2022 Tape Formulation for Different Application Sites and Intervals in Japanese Healthy Elderly Males | Biotech Hunter | Biotech Hunter